Compounds > 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride
Page last updated: 2024-09-05

1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride and Pregnancy

1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride has been researched along with Pregnancy in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, TH; Chung, MK; Jang, BS; Kang, SS; Kim, CY; Kim, JC; Kim, SH; Shin, DH1
Bae, CS; Chung, MK; Han, J; Kim, JC; Kim, SH; Park, SC; Shin, HC; Yun, HI1
Amidon, GL; Chung, MK; Jung, YH; Kim, JC; Kim, JS; Lee, MK; Shin, HC1
Chung, MK; Jung, YH; Kim, JC; Kim, SH; Kwon, HJ; Oh, KS; Shin, DH; Shin, HC; Yun, HI1
Chung, MK; Han, SS; Kim, JC; Shin, HC; Yun, HI1

Other Studies

5 other study(ies) available for 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride and Pregnancy

ArticleYear
Developmental toxicity evaluation of the new fluoroquinolone antibacterial DW-116 in rats.
    Teratogenesis, carcinogenesis, and mutagenesis, 2003, Volume: Suppl 1

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Infective Agents; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Female; Fetal Weight; Fetus; Fluoroquinolones; Gestational Age; Maternal-Fetal Exchange; Molecular Structure; Organ Size; Piperazines; Placenta; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley

2003
Transplacental pharmacokinetics of the new fluoroquinolone DW-116 in pregnant rats.
    Toxicology letters, 2003, Apr-30, Volume: 142, Issue:1-2

    Topics: Amniotic Fluid; Animals; Anti-Infective Agents; Area Under Curve; Embryonic and Fetal Development; Female; Fetus; Fluoroquinolones; Half-Life; Male; Maternal-Fetal Exchange; Piperazines; Placenta; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley

2003
Fetal and maternal tissue distribution of the new fluoroquinolone DW-116 in pregnant rats.
    Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2003, Volume: 136, Issue:1

    Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Bacterial Agents; Area Under Curve; Carbon Radioisotopes; Female; Fetus; Fluoroquinolones; Lactation; Maternal-Fetal Exchange; Piperazines; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Tissue Distribution

2003
Peri- and postnatal developmental toxicity of the fluoroquinolone antibacterial DW-116 in rats.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2004, Volume: 42, Issue:3

    Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Bacterial Agents; Behavior, Animal; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Longevity; Male; Maternal Exposure; No-Observed-Adverse-Effect Level; Piperazines; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley; Reproduction; Sexual Maturation; Specific Pathogen-Free Organisms

2004
Embryo lethality and teratogenicity of a new fluoroquinolone antibacterial DW-116 in rats.
    Archives of toxicology, 2000, Volume: 74, Issue:2

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Infective Agents; Body Weight; Bone and Bones; Eating; Female; Fetal Death; Fluoroquinolones; Male; Maternal-Fetal Exchange; Piperazines; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley; Teratogens

2000